Back to Search Start Over

124 Phase II Randomized Trial of Optimal Recurrence-Directed Therapy (RDT) Without or with Androgen-Deprivation Therapy (ADT) in Radio-Recurrent Oligo-Metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC): The OCOG-Rational-PCS Trial.

Subjects

Subjects :
*PROSTATE cancer
*HORMONES

Details

Language :
English
ISSN :
01678140
Volume :
198
Database :
Academic Search Index
Journal :
Radiotherapy & Oncology
Publication Type :
Academic Journal
Accession number :
180493554
Full Text :
https://doi.org/10.1016/S0167-8140(24)03611-9